242 related articles for article (PubMed ID: 37799715)
1. Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT.
Zeven K; De Groof TWM; Ceuppens H; Awad RM; Ertveldt T; de Mey W; Meeus F; Raes G; Breckpot K; Devoogdt N
Front Immunol; 2023; 14():1268900. PubMed ID: 37799715
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use.
Lecocq Q; Zeven K; De Vlaeminck Y; Martens S; Massa S; Goyvaerts C; Raes G; Keyaerts M; Breckpot K; Devoogdt N
Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31569553
[TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of nanobodies targeting PSMA for molecular imaging of prostate cancer.
Evazalipour M; D'Huyvetter M; Tehrani BS; Abolhassani M; Omidfar K; Abdoli S; Arezumand R; Morovvati H; Lahoutte T; Muyldermans S; Devoogdt N
Contrast Media Mol Imaging; 2014; 9(3):211-20. PubMed ID: 24700748
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.
Gainkam LO; Huang L; Caveliers V; Keyaerts M; Hernot S; Vaneycken I; Vanhove C; Revets H; De Baetselier P; Lahoutte T
J Nucl Med; 2008 May; 49(5):788-95. PubMed ID: 18413403
[TBL] [Abstract][Full Text] [Related]
5. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
[TBL] [Abstract][Full Text] [Related]
6. Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.
Vaneycken I; Devoogdt N; Van Gassen N; Vincke C; Xavier C; Wernery U; Muyldermans S; Lahoutte T; Caveliers V
FASEB J; 2011 Jul; 25(7):2433-46. PubMed ID: 21478264
[TBL] [Abstract][Full Text] [Related]
7. In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT/micro-CT.
Vaneycken I; Govaert J; Vincke C; Caveliers V; Lahoutte T; De Baetselier P; Raes G; Bossuyt A; Muyldermans S; Devoogdt N
J Nucl Med; 2010 Jul; 51(7):1099-106. PubMed ID: 20554727
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive Evaluation of Tumoral PD-L1 Using a Novel
Hu B; Ma X; Shi L; Liu T; Li L; Yao M; Li C; Jia B
Mol Pharm; 2024 Apr; 21(4):1977-1986. PubMed ID: 38395797
[TBL] [Abstract][Full Text] [Related]
9. Preclinical and exploratory human studies of novel
Wang X; Zhou M; Chen B; Liu H; Fang J; Xiang S; Hu S; Zhang X
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2584-2594. PubMed ID: 35037984
[TBL] [Abstract][Full Text] [Related]
10. Non-Invasive Imaging of Amyloid Deposits in a Mouse Model of AGel Using
Verhelle A; Van Overbeke W; Peleman C; De Smet R; Zwaenepoel O; Lahoutte T; Van Dorpe J; Devoogdt N; Gettemans J
Mol Imaging Biol; 2016 Dec; 18(6):887-897. PubMed ID: 27130233
[TBL] [Abstract][Full Text] [Related]
11. Imaging of Glioblastoma Tumor-Associated Myeloid Cells Using Nanobodies Targeting Signal Regulatory Protein Alpha.
De Vlaminck K; Romão E; Puttemans J; Pombo Antunes AR; Kancheva D; Scheyltjens I; Van Ginderachter JA; Muyldermans S; Devoogdt N; Movahedi K; Raes G
Front Immunol; 2021; 12():777524. PubMed ID: 34917090
[TBL] [Abstract][Full Text] [Related]
12. Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis.
Zheng F; Put S; Bouwens L; Lahoutte T; Matthys P; Muyldermans S; De Baetselier P; Devoogdt N; Raes G; Schoonooghe S
J Nucl Med; 2014 May; 55(5):824-9. PubMed ID: 24686780
[TBL] [Abstract][Full Text] [Related]
13. PET Imaging of TIGIT Expression on Tumor-Infiltrating Lymphocytes.
Shaffer T; Natarajan A; Gambhir SS
Clin Cancer Res; 2021 Apr; 27(7):1932-1940. PubMed ID: 33408249
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions.
Broisat A; Hernot S; Toczek J; De Vos J; Riou LM; Martin S; Ahmadi M; Thielens N; Wernery U; Caveliers V; Muyldermans S; Lahoutte T; Fagret D; Ghezzi C; Devoogdt N
Circ Res; 2012 Mar; 110(7):927-37. PubMed ID: 22461363
[TBL] [Abstract][Full Text] [Related]
15. The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery.
Debie P; Declerck NB; van Willigen D; Huygen CM; De Sloovere B; Mateusiak L; Bridoux J; Puttemans J; Devoogdt N; van Leeuwen FWB; Hernot S
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33652977
[TBL] [Abstract][Full Text] [Related]
16. ImmunoPET imaging of human CD8
Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
[TBL] [Abstract][Full Text] [Related]
17. A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade.
Ma L; Gai J; Qiao P; Li Y; Li X; Zhu M; Li G; Wan Y
Biochem Biophys Res Commun; 2020 Oct; 531(2):144-151. PubMed ID: 32782142
[TBL] [Abstract][Full Text] [Related]
18. Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade.
Lecocq Q; Awad RM; De Vlaeminck Y; de Mey W; Ertveldt T; Goyvaerts C; Raes G; Thielemans K; Keyaerts M; Devoogdt N; Breckpot K
J Nucl Med; 2021 Nov; 62(11):1638-1644. PubMed ID: 33712537
[TBL] [Abstract][Full Text] [Related]
19. Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages.
Movahedi K; Schoonooghe S; Laoui D; Houbracken I; Waelput W; Breckpot K; Bouwens L; Lahoutte T; De Baetselier P; Raes G; Devoogdt N; Van Ginderachter JA
Cancer Res; 2012 Aug; 72(16):4165-77. PubMed ID: 22719068
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
